MARKET

TRIB

TRIB

Trinity Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.420
+0.550
+14.21%
Closed 16:00 11/27 EST
OPEN
3.940
PREV CLOSE
3.870
HIGH
4.460
LOW
3.939
VOLUME
532.71K
TURNOVER
--
52 WEEK HIGH
4.460
52 WEEK LOW
0.5610
MARKET CAP
106.26M
P/E (TTM)
-24.1794
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Is Trinity Biotech plc (TRIB) A Good Stock To Buy?
Insider Monkey · 2d ago
The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24)
Benzinga · 4d ago
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 23)
Benzinga · 5d ago
Medigus, 180 Life Sciences leads healthcare gainers; Bellerophon Therapeutics, BioLineRx among major losers
Gainers: Medigus (MDGS) +36%, 180 Life Sciences (ATNF) +35%, Graybug Vision (GRAY) +23%, Trinity Biotech (TRIB) +18%, Accuray (ARAY) +14%.Losers: Bellerophon Therapeutics (BLPH) -18%, BioLineRx (BLRX) -13%, AIM ImmunoTech (AIM) -11%, iBio (IBIO) -10%, OptiNose (OPTN) -10%.
Seekingalpha · 6d ago
The Daily Biotech Pulse:Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 17)
Benzinga · 11/18 12:29
Trinity Biotech EPS beats by $0.22, beats on revenue
Trinity Biotech (TRIB): Q3 Non-GAAP EPS of $0.36; GAAP EPS of $0.32 beats by $0.22.Revenue of $32.01M (+30.2% Y/Y) beats by $4.01M.Press Release
Seekingalpha · 11/17 14:24
Trinity Biotech Plc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 17, 2020 / Trinity Biotech Plc (NASDAQ:TRIB) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 17, 2020 at 11:00 AM Eastern Time.
ACCESSWIRE · 11/17 14:15
Trinity Biotech Q3 EPS $0.32 Up From $0.04 YoY, Sales $32.00M Beat $21.18M Estimate
Trinity Biotech (NASDAQ:TRIB) reported quarterly earnings of $0.32 per share. This is a 648.84 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of
Benzinga · 11/17 14:13
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TRIB. Analyze the recent business situations of Trinity Biotech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TRIB stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 51
Institutional Holdings: 7.79M
% Owned: 32.39%
Shares Outstanding: 24.04M
TypeInstitutionsShares
Increased
7
616.99K
New
12
-233.02K
Decreased
4
1.42M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.62%
Healthcare Equipment & Supplies
+1.44%
Key Executives
Chairman/Director
Ronan O'Caoimh
Chief Financial Officer/Secretary/IR Contact Officer
Kevin Tansley
Chief Operating Officer/Executive Director
Rory Nealon
Chief Scientific Officer/Vice President
Eric Brouwer
Executive Director
James Walsh
Non-Executive Director
Clinton Severson
Non-Executive Independent Director
Denis Burger
Non-Executive Independent Director
Peter Coyne
Non-Executive Independent Director
James Merselis
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.22
06/05/2015
--
Dividend USD 0.22
06/06/2014
05/31/2013
Dividend USD 0.2
06/06/2013
06/05/2012
Dividend USD 0.15
06/06/2012
--
Dividend USD 0.1
06/07/2011
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About TRIB
Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Trinity Biotech plc (ADR) stock information, including NASDAQ:TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.